Health Boards
Fred this is what is on the info given to me.
WHAT IS THE PURPOSE OF THE STUDY?
Our study is taking place internationally and there will be about 300 other patients all around the world who will be taking part including approximately 15 patients in the UK. It will take about two years to complete the whole study but your participation in the study is expected to last up to one year and three months.
The main reason for you to take part in this study is not to treat you for your condition, we hope that the results of this study will help to answer the following research question:
• Can ixekizumab help patients with moderate-to-severe plaque psoriasis.
So I guess the answer would be no.
( Sorry Fred I do not suffer from arthritis yet.)
WHAT IS THE PURPOSE OF THE STUDY?
Our study is taking place internationally and there will be about 300 other patients all around the world who will be taking part including approximately 15 patients in the UK. It will take about two years to complete the whole study but your participation in the study is expected to last up to one year and three months.
The main reason for you to take part in this study is not to treat you for your condition, we hope that the results of this study will help to answer the following research question:
• Can ixekizumab help patients with moderate-to-severe plaque psoriasis.
So I guess the answer would be no.
( Sorry Fred I do not suffer from arthritis yet.)